A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma

Songyih Kim, Jae Lee Ik, Yongbae Kim, Sub Koom Woong, Chul Jeon Byeong, Geol Lee Chang, Eon Kim Gwi, Chang Keum Ki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This study evaluated whether helical tomotherapy (TOMO) planning could achieve better isodose distribution for the maxillary sinus while concomitantly sparing the adjacent critical normal organs than linac-based step-and-shoot IMRT (s-IMRT) planning. TOMO and s-IMRT were established for 10 patients with maxillary sinus cancer. The prescription (66 Gy, 30 fractions) was used to cover the planning target volume (PTV) with a 95% isodose line. Each plan was independently optimized using the CORVUS planning system and Tomotherapy Hi-Art system. The treatment plans were compared using dose volume histogram (DVH), a dose homogeneity index (DHI) of the PTV, and equivalent uniform dose (EUD) and DVH of organs at risk (OARs). The TOMO plans demonstrated better dose homogeneity compared to the s-IMRT plans. The average V95% of the TOMO plans was similar to that of the s-IMRT (92.92% vs. 95.07%, respectively), but the average V107% was 0% for TOMO compared with 18.74% for s-IMRT. The average maximum dose reduction was 7 Gy, and DHI increased by 8% for PTV1 in TOMO compared with s-IMRT (79 Gy vs. 71 Gy and, 89% vs. 97%, respectively). The average EUD reduction for the optic nerve was 17%. In summary, planning with TOMO was superior to s-IMRT planning with respect to dose homogeneity within the PTV and sparing of the optic nerve.

Original languageEnglish
Pages (from-to)257-263
Number of pages7
JournalTechnology in Cancer Research and Treatment
Volume8
Issue number4
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Intensity-Modulated Radiotherapy
Maxillary Sinus
Optic Nerve
Maxillary Sinus Neoplasms
Radiotherapy
Organs at Risk
Carcinoma
Art
Prescriptions
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kim, Songyih ; Ik, Jae Lee ; Kim, Yongbae ; Woong, Sub Koom ; Byeong, Chul Jeon ; Chang, Geol Lee ; Gwi, Eon Kim ; Ki, Chang Keum. / A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma. In: Technology in Cancer Research and Treatment. 2009 ; Vol. 8, No. 4. pp. 257-263.
@article{316d0dcb943e43c98544d15aa79c3726,
title = "A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma",
abstract = "This study evaluated whether helical tomotherapy (TOMO) planning could achieve better isodose distribution for the maxillary sinus while concomitantly sparing the adjacent critical normal organs than linac-based step-and-shoot IMRT (s-IMRT) planning. TOMO and s-IMRT were established for 10 patients with maxillary sinus cancer. The prescription (66 Gy, 30 fractions) was used to cover the planning target volume (PTV) with a 95{\%} isodose line. Each plan was independently optimized using the CORVUS planning system and Tomotherapy Hi-Art system. The treatment plans were compared using dose volume histogram (DVH), a dose homogeneity index (DHI) of the PTV, and equivalent uniform dose (EUD) and DVH of organs at risk (OARs). The TOMO plans demonstrated better dose homogeneity compared to the s-IMRT plans. The average V95{\%} of the TOMO plans was similar to that of the s-IMRT (92.92{\%} vs. 95.07{\%}, respectively), but the average V107{\%} was 0{\%} for TOMO compared with 18.74{\%} for s-IMRT. The average maximum dose reduction was 7 Gy, and DHI increased by 8{\%} for PTV1 in TOMO compared with s-IMRT (79 Gy vs. 71 Gy and, 89{\%} vs. 97{\%}, respectively). The average EUD reduction for the optic nerve was 17{\%}. In summary, planning with TOMO was superior to s-IMRT planning with respect to dose homogeneity within the PTV and sparing of the optic nerve.",
author = "Songyih Kim and Ik, {Jae Lee} and Yongbae Kim and Woong, {Sub Koom} and Byeong, {Chul Jeon} and Chang, {Geol Lee} and Gwi, {Eon Kim} and Ki, {Chang Keum}",
year = "2009",
month = "1",
day = "1",
doi = "10.1177/153303460900800402",
language = "English",
volume = "8",
pages = "257--263",
journal = "Technology in Cancer Research and Treatment",
issn = "1533-0346",
publisher = "Adenine Press",
number = "4",

}

A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma. / Kim, Songyih; Ik, Jae Lee; Kim, Yongbae; Woong, Sub Koom; Byeong, Chul Jeon; Chang, Geol Lee; Gwi, Eon Kim; Ki, Chang Keum.

In: Technology in Cancer Research and Treatment, Vol. 8, No. 4, 01.01.2009, p. 257-263.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A comparison of treatment plans using linac-based intensity-modulated radiation therapy and helical tomotherapy for maxillary sinus carcinoma

AU - Kim, Songyih

AU - Ik, Jae Lee

AU - Kim, Yongbae

AU - Woong, Sub Koom

AU - Byeong, Chul Jeon

AU - Chang, Geol Lee

AU - Gwi, Eon Kim

AU - Ki, Chang Keum

PY - 2009/1/1

Y1 - 2009/1/1

N2 - This study evaluated whether helical tomotherapy (TOMO) planning could achieve better isodose distribution for the maxillary sinus while concomitantly sparing the adjacent critical normal organs than linac-based step-and-shoot IMRT (s-IMRT) planning. TOMO and s-IMRT were established for 10 patients with maxillary sinus cancer. The prescription (66 Gy, 30 fractions) was used to cover the planning target volume (PTV) with a 95% isodose line. Each plan was independently optimized using the CORVUS planning system and Tomotherapy Hi-Art system. The treatment plans were compared using dose volume histogram (DVH), a dose homogeneity index (DHI) of the PTV, and equivalent uniform dose (EUD) and DVH of organs at risk (OARs). The TOMO plans demonstrated better dose homogeneity compared to the s-IMRT plans. The average V95% of the TOMO plans was similar to that of the s-IMRT (92.92% vs. 95.07%, respectively), but the average V107% was 0% for TOMO compared with 18.74% for s-IMRT. The average maximum dose reduction was 7 Gy, and DHI increased by 8% for PTV1 in TOMO compared with s-IMRT (79 Gy vs. 71 Gy and, 89% vs. 97%, respectively). The average EUD reduction for the optic nerve was 17%. In summary, planning with TOMO was superior to s-IMRT planning with respect to dose homogeneity within the PTV and sparing of the optic nerve.

AB - This study evaluated whether helical tomotherapy (TOMO) planning could achieve better isodose distribution for the maxillary sinus while concomitantly sparing the adjacent critical normal organs than linac-based step-and-shoot IMRT (s-IMRT) planning. TOMO and s-IMRT were established for 10 patients with maxillary sinus cancer. The prescription (66 Gy, 30 fractions) was used to cover the planning target volume (PTV) with a 95% isodose line. Each plan was independently optimized using the CORVUS planning system and Tomotherapy Hi-Art system. The treatment plans were compared using dose volume histogram (DVH), a dose homogeneity index (DHI) of the PTV, and equivalent uniform dose (EUD) and DVH of organs at risk (OARs). The TOMO plans demonstrated better dose homogeneity compared to the s-IMRT plans. The average V95% of the TOMO plans was similar to that of the s-IMRT (92.92% vs. 95.07%, respectively), but the average V107% was 0% for TOMO compared with 18.74% for s-IMRT. The average maximum dose reduction was 7 Gy, and DHI increased by 8% for PTV1 in TOMO compared with s-IMRT (79 Gy vs. 71 Gy and, 89% vs. 97%, respectively). The average EUD reduction for the optic nerve was 17%. In summary, planning with TOMO was superior to s-IMRT planning with respect to dose homogeneity within the PTV and sparing of the optic nerve.

UR - http://www.scopus.com/inward/record.url?scp=68949215123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949215123&partnerID=8YFLogxK

U2 - 10.1177/153303460900800402

DO - 10.1177/153303460900800402

M3 - Article

C2 - 19645518

AN - SCOPUS:68949215123

VL - 8

SP - 257

EP - 263

JO - Technology in Cancer Research and Treatment

JF - Technology in Cancer Research and Treatment

SN - 1533-0346

IS - 4

ER -